In a filing, Upstream Bio Inc revealed its Director Chimovits Erez acquired Company’s shares for reported $14.03 million on Oct 15 ’24. In the deal valued at $17.00 per share,825,000 shares were bought. As a result of this transaction, Chimovits Erez now holds 4,554,873 shares worth roughly $37.4 million.
Then, ORBIMED ADVISORS LLC bought 825,000 shares, generating $14,025,000 in total proceeds. Upon buying the shares at $17.00, the Director now owns 4,554,873 shares.
Before that, AI Upstream LLC bought 1,175,000 shares. Upstream Bio Inc shares valued at $19,975,000 were divested by the 10% Owner at a price of $17.00 per share. As a result of the transaction, AI Upstream LLC now holds 1,175,000 shares, worth roughly $9.65 million.
William Blair initiated its Upstream Bio Inc [UPB] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in early November with a ‘”a Buy”‘ rating. Piper Sandler began covering UPB with “an Overweight” recommendation on November 05, 2024. JP Morgan started covering the stock on November 05, 2024. It rated UPB as “an Overweight”.
Price Performance Review of UPB
On Tuesday, Upstream Bio Inc [NASDAQ:UPB] saw its stock fall -5.41% to $8.21. Over the last five days, the stock has lost -8.57%. Upstream Bio Inc shares have fallen nearly -50.06% since the year began.
Levels Of Support And Resistance For UPB Stock
The 24-hour chart illustrates a support level at 7.70, which if violated will result in even more drops to 7.19. On the upside, there is a resistance level at 8.81. A further resistance level may holdings at 9.41. The Relative Strength Index (RSI) on the 14-day chart is 48.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.40, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.83%. Stochastics %K at 35.73% indicates the stock is a holding.
